Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             62 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going? Le Chevalier, T.

21 S7 p. vii196-vii198
artikel
2 Advances in neuroendocrine lung tumors Travis, W.D.

21 S7 p. vii65-vii71
artikel
3 Advances in systemic treatment of melanoma Eggermont, A.M.M.

21 S7 p. vii339-vii344
artikel
4 Advances in the treatment of metastatic or unresectable biliary tract cancer Valle, J.W.

21 S7 p. vii345-vii348
artikel
5 Anemia in cancer Dicato, M.

21 S7 p. vii167-vii172
artikel
6 Benefits and adverse effects of endocrine therapy Colleoni, M.

21 S7 p. vii107-vii111
artikel
7 Cancer of unknown primary site: 20 questions to be answered Pavlidis, N.

21 S7 p. vii303-vii307
artikel
8 Cancer stem cells Cordon-Cardo, C.

21 S7 p. vii93-vii94
artikel
9 Cardiotoxicity Brana, I.

21 S7 p. vii173-vii179
artikel
10 Chemotherapy: which drug and when? Sobrero, A.

21 S7 p. vii130-vii133
artikel
11 Chemotherapy with or without trastuzumab Oakman, C.

21 S7 p. vii112-vii119
artikel
12 Chronic lymphocytic leukemia Hallek, Michael

21 S7 p. vii154-vii164
artikel
13 Circulating cancer cells Mavroudis, D.

21 S7 p. vii95-vii100
artikel
14 Consequences of targeted treatments for second-line therapy De Maio, E.

21 S7 p. vii234-vii240
artikel
15 Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer? Konopa, K.

21 S7 p. vii199-vii202
artikel
16 Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging Vansteenkiste, J.

21 S7 p. vii189-vii195
artikel
17 Editorial Board
21 S7 p. ii-iii
artikel
18 ESMO Education
21 S7 p. vii5-vii7
artikel
19 ESMO Educational and Scientific activities
21 S7 p. vii10-vii11
artikel
20 ESMO Fellowship Program
21 S7 p. vii12-vii16
artikel
21 ESMO-MORA
21 S7 p. vii8-vii9
artikel
22 European Society for Medical Oncology Committees
21 S7 p. vii18-vii19
artikel
23 Follicular lymphoma Ghielmini, M.

21 S7 p. vii151-vii153
artikel
24 Gastrointestinal neuroendocrine tumors Öberg, K.E.

21 S7 p. vii72-vii80
artikel
25 Genetic counselling for hereditary predisposition to ovarian and breast cancer Mackay, J.

21 S7 p. vii334-vii338
artikel
26 Histology-driven chemotherapy of soft-tissue sarcoma Eriksson, M.

21 S7 p. vii270-vii276
artikel
27 Horizon scanning for novel therapeutics for the treatment of prostate cancer Bianchini, D.

21 S7 p. vii43-vii55
artikel
28 How to integrate current knowledge in selecting patients for first line in NSCLC? Felip, E.

21 S7 p. vii230-vii233
artikel
29 How to integrate molecular targeted agents in the continuum of care Köhne, C.-H.

21 S7 p. vii134-vii139
artikel
30 How to select targeted therapy in renal cell cancer Escudier, B.

21 S7 p. vii59-vii62
artikel
31 Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer Posner, M.R.

21 S7 p. vii246-vii251
artikel
32 Introduction from the ESMO 2010 Educational Committee Chair
21 S7 p. vii24
artikel
33 Is there any role for surgery in the multidisciplinary treatment of esophageal cancer? Stahl, M.

21 S7 p. vii283-vii285
artikel
34 Merkel cell carcinoma Becker, J.C.

21 S7 p. vii81-vii85
artikel
35 Mesothelioma Weder, W.

21 S7 p. vii326-vii333
artikel
36 Multimodality treatment for localized gastro-oesophageal cancer Okines, A.F.C.

21 S7 p. vii286-vii293
artikel
37 Multiple myeloma Dimopoulos, M.A.

21 S7 p. vii143-vii150
artikel
38 Multiple myeloma Bladé, J.

21 S7 p. vii313-vii319
artikel
39 Nasopharyngeal carcinoma Chan, A.T.C.

21 S7 p. vii308-vii312
artikel
40 New agents for bladder cancer Bellmunt, J.

21 S7 p. vii56-vii58
artikel
41 New trends for staging and therapy for localized gastroesophageal cancer: the role of PET Lordick, F.

21 S7 p. vii294-vii299
artikel
42 Optimal treatment for recurrent/metastatic head and neck cancer Vermorken, J.B.

21 S7 p. vii252-vii261
artikel
43 Optimal treatment for relapsing ovarian cancer Ledermann, J.A.

21 S7 p. vii218-vii222
artikel
44 Osteosarcoma Ritter, J.

21 S7 p. vii320-vii325
artikel
45 Prevention and treatment of side-effects of systemic treatment: bone loss Body, J.-J.

21 S7 p. vii180-vii185
artikel
46 Proteomics as a guiding tool for more effective personalized therapy Lee, J.-M.

21 S7 p. vii205-vii210
artikel
47 Should we continue to use the term non-small-cell lung cancer? Gazdar, A.F.

21 S7 p. vii225-vii229
artikel
48 Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies Wardelmann, E.

21 S7 p. vii265-vii269
artikel
49 Table of Contents
21 S7 p. v-vi
artikel
50 Targeted therapies in soft tissue sarcomas Judson, I.

21 S7 p. vii277-vii280
artikel
51 The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer Bookman, M.A.

21 S7 p. vii211-vii217
artikel
52 The epithelial–mesenchymal transition (EMT) phenomenon Savagner, P.

21 S7 p. vii89-vii92
artikel
53 The role of human papillomavirus infection in head and neck cancers Syrjänen, S.

21 S7 p. vii243-vii245
artikel
54 35th ESMO Congress Officers
21 S7 p. vii20-vii21
artikel
55 35th ESMO Congress Organization
21 S7 p. vii22-vii23
artikel
56 Title Page
21 S7 p. iv
artikel
57 Treatment of HER2-overexpressing breast cancer Baselga, J.

21 S7 p. vii36-vii40
artikel
58 Treatment of pT1N0 breast cancer: multigene predictors to assess risk of relapse Fumagalli, D.

21 S7 p. vii103-vii106
artikel
59 Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization? Berrada, N.

21 S7 p. vii30-vii35
artikel
60 What can the molecular pathologist offer for optimal decision making? Richman, S.D.

21 S7 p. vii123-vii129
artikel
61 What can the pathologist offer for optimal treatment choice? Viale, G.

21 S7 p. vii27-vii29
artikel
62 Young Oncologists
21 S7 p. vii17
artikel
                             62 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland